)
Holger Klein
Senior Principal Scientist Computational Biology,
Boehringer Ingelheim
I specialize in turning high-dimensional omics data into therapeutic targets. Having lived and worked in both Germany and the US, the academic and private sector, I thrive at the intersection of cross-functional leadership and cutting-edge CompBio and Data Science applications in pharma.
Sessions
-
Multimodal Identification of Disease Segments28-Jan-2027AI In Drug Discovery Stage